23
Nov
2020
Medicines Based on Unusual Genetic Traits: Andrew Farnum on The Long Run
Today’s guest on The Long Run is Andrew Farnum. Andrew is the CEO of Seattle-based Variant Bio. Variant Bio is a startup seeking to discover new drugs, by finding gene variants in rare ethnic groups. It’s especially interested in what can be learned by sequencing exceptional groups of people in countries where there hasn’t been much sequencing. This is a... Read More
23
Nov
2020
A New Model for Vaccine Communications Grounded in Science and Empathy
With COVID-19 cases, hospitalizations and deaths surging, the impressive vaccine results from Pfizer/BioNTech, Moderna and now AstraZeneca arrive just in time to provide some needed hope. But for these vaccines to bring the pandemic to an end, enough people need to be willing to take them. That’s not a given. Various polls have told a story this year about a rising tide... Read More